Indeed, we demonstrated that the retargeted virus efficiently infected and killed GFRα1-positive, but not GFRα1-negative, breast cancer cells in vitro, and knockdown of GFRα1 protein expression significantly reduced retargeted virus infection. The gene discussed is GFRA1; the disease is viral infectious disease.